ACUSHNET HOLDINGS CORP., 10-Q filed on 5/7/2025
Quarterly Report
v3.25.1
Cover Page - shares
 3 Months Ended
Mar. 31, 2025
May 01, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2025  
Document Transition Report false  
Entity File Number 001-37935  
Entity Registrant Name Acushnet Holdings Corp.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 45-2644353  
Entity Address, Address Line One 333 Bridge Street  
Entity Address, City or Town Fairhaven,  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02719  
City Area Code 800  
Local Phone Number 225-8500  
Title of 12(b) Security Common Stock - $0.001 par value per share  
Trading Symbol GOLF  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   58,766,256
Entity Central Index Key 0001672013  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash, cash equivalents and restricted cash ($0 and $10,647 attributable to the variable interest entity ("VIE")) $ 40,599 $ 53,059
Accounts receivable, net 477,347 218,368
Inventories ($0 and $3,667 attributable to the VIE) 538,141 575,964
Prepaid and other assets 132,843 126,482
Total current assets 1,188,930 973,873
Property, plant and equipment, net ($0 and $8,135 attributable to the VIE) 319,063 325,747
Goodwill ($0 and $32,312 attributable to the VIE) 221,869 220,136
Intangible assets, net 519,711 523,131
Deferred income taxes 30,050 34,306
Other assets ($0 and $1,884 attributable to the VIE) 123,004 103,013
Total assets 2,402,627 2,180,206
Current liabilities    
Short-term debt 17,345 10,160
Current portion of long-term debt 751 722
Accounts payable ($0 and $2,400 attributable to the VIE) 187,289 150,322
Accrued taxes 52,022 36,009
Accrued compensation and benefits ($0 and $643 attributable to the VIE) 58,899 95,064
Accrued expenses and other liabilities ($0 and $13,893 attributable to the VIE) 221,889 180,430
Total current liabilities 538,195 472,707
Long-term debt 926,092 753,081
Deferred income taxes 7,990 8,107
Accrued pension and other postretirement benefits 69,754 74,410
Other noncurrent liabilities 76,347 74,737
Total liabilities 1,618,378 1,383,042
Commitments and contingencies (Note 15)
Redeemable noncontrolling interests 3,965 4,028
Shareholders' equity    
Common stock, $0.001 par value, 500,000,000 shares authorized; 60,920,931 and 61,214,541 shares issued 61 61
Additional paid-in capital 778,071 787,725
Accumulated other comprehensive loss, net of tax (133,852) (140,315)
Retained earnings 235,141 180,276
Treasury stock, at cost (including 1,476,851 and 935,907 of accrued share repurchases) (Note 10) (99,137) (62,500)
Total equity attributable to Acushnet Holdings Corp. 780,284 765,247
Noncontrolling interests 0 27,889
Total shareholders' equity 780,284 793,136
Total liabilities, redeemable noncontrolling interests and shareholders' equity $ 2,402,627 $ 2,180,206
v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Cash, cash equivalents and restricted cash $ 40,599 $ 53,059
Inventories 538,141 575,964
Property, plant and equipment, net 319,063 325,747
Goodwill 221,869 220,136
Other assets 123,004 103,013
Accounts payable 187,289 150,322
Accrued compensation and benefits 58,899 95,064
Accrued expenses and other liabilities $ 221,889 $ 180,430
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 60,920,931 61,214,541
Accrued share repurchase (in shares) 1,476,851 935,907
VIE    
Cash, cash equivalents and restricted cash $ 0 $ 10,647
Inventories 0 3,667
Property, plant and equipment, net 0 8,135
Goodwill 0 32,312
Other assets 0 1,884
Accounts payable 0 2,400
Accrued compensation and benefits 0 643
Accrued expenses and other liabilities $ 0 $ 13,893
v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net sales $ 703,372 $ 707,554
Cost of goods sold 366,210 365,202
Gross profit 337,162 342,352
Operating expenses:    
Selling, general and administrative 200,261 201,005
Research and development 18,859 16,453
Intangible amortization 3,495 3,513
Income from operations 114,547 121,381
Interest expense, net 13,815 13,076
Other (income) expense, net (19,863) 339
Income before income taxes 120,595 107,966
Income tax expense 21,570 23,407
Net income 99,025 84,559
Less: Net loss attributable to noncontrolling interests 347 3,203
Net income attributable to Acushnet Holdings Corp. $ 99,372 $ 87,762
Net income per common share attributable to Acushnet Holdings Corp.:    
Basic (in dollars per share) $ 1.62 $ 1.36
Diluted (in dollars per share) $ 1.62 $ 1.35
Weighted average number of common shares:    
Basic (in shares) 61,325,623 64,621,122
Diluted (in shares) 61,484,788 64,889,174
v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Comprehensive Income [Abstract]    
Net income $ 99,025 $ 84,559
Other comprehensive income (loss):    
Foreign currency translation adjustments 8,894 (12,071)
Cash flow derivative instruments:    
Unrealized holding (losses) gains arising during period (2,160) 3,921
Reclassification adjustments included in net income (414) (2,998)
Tax benefit (expense) 739 (203)
Cash flow derivative instruments, net (1,835) 720
Pension and other postretirement benefits:    
Pension and other postretirement benefits adjustments (645) (90)
Tax benefit 127 20
Pension and other postretirement benefits adjustments, net (518) (70)
Total other comprehensive income (loss) 6,541 (11,421)
Comprehensive income 105,566 73,138
Less: Comprehensive loss attributable to noncontrolling interests 269 3,494
Comprehensive income attributable to Acushnet Holdings Corp. $ 105,835 $ 76,632
v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities    
Net income $ 99,025 $ 84,559
Adjustments to reconcile net income to cash flows used in operating activities    
Depreciation and amortization 14,277 13,781
Unrealized foreign exchange gain (2,085) (350)
Amortization of debt issuance costs 452 431
Share-based compensation 6,941 7,424
Loss on disposals of property, plant and equipment 385 424
Deferred income taxes 4,885 4,541
Gain on deconsolidation of VIE (Note 1) (20,887) 0
Loss from equity method investment (Note 1) 223 0
Changes in operating assets and liabilities    
Accounts receivable (254,549) (267,847)
Inventories 42,496 69,891
Accounts payable 35,926 (1,419)
Accrued taxes 14,483 12,340
Other assets and liabilities (61,826) (33,291)
Cash flows used in operating activities (120,254) (109,516)
Cash flows from investing activities    
Additions to property, plant and equipment (11,263) (7,275)
Cash flows used in investing activities (11,263) (7,275)
Cash flows from financing activities    
Proceeds from credit facilities (Note $5) 401,522 436,709
Repayments of credit facilities (Note $5) (223,230) (271,829)
Purchases of common stock (35,683) (33,322)
Dividends paid on common stock (14,778) (14,630)
Payment of employee restricted stock tax withholdings (9,686) (15,357)
Cash flows provided by financing activities 118,145 101,571
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash 912 (1,493)
Net decrease in cash, cash equivalents and restricted cash (12,460) (16,713)
Cash, cash equivalents and restricted cash, beginning of year 53,059 65,435
Cash, cash equivalents and restricted cash, end of period 40,599 48,722
Supplemental non-cash information    
Purchases of property, plant and equipment, accrued not paid 2,439 3,923
Additions to right-of-use assets obtained in exchange for operating lease obligations 5,345 3,274
Additions to right-of-use assets obtained in exchange for finance lease obligations 0 434
Dividend equivalents rights ("DERs") declared not paid 506 496
Additions to share repurchase liability (Note 10) $ 36,637 $ 0
v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($)
shares in Thousands, $ in Thousands
Total
Total Shareholders' Equity Attributable to Acushnet Holdings Corp.
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Tax
Retained Earnings
Treasury Stock
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023     63,429          
Beginning balance at Dec. 31, 2023 $ 903,087 $ 864,235 $ 63 $ 808,615 $ (104,349) $ 159,906 $ 0 $ 38,852
Changes in stockholders' equity                
Net income (loss) 84,613 87,762       87,762   (3,149)
Other comprehensive income (loss) (11,130) (11,130)     (11,130)      
Share-based compensation 7,260 7,260   7,260        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     406          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (14,934) (14,934)   (14,934)        
Purchases of common stock (Note 10) (in shares)     (547)          
Purchases of common stock (Note 10) (35,302) (35,302)   (6,870)   (28,432)    
Share repurchase liability (Note 10) 0              
Dividends and dividend equivalents declared (14,155) (14,155)       (14,155)    
Ending balance (in shares) at Mar. 31, 2024     63,288          
Ending balance at Mar. 31, 2024 919,439 883,736 $ 63 794,071 (115,479) 205,081 0 35,703
Beginning balance (in shares) at Dec. 31, 2023     63,429          
Beginning balance at Dec. 31, 2023 903,087 864,235 $ 63 808,615 (104,349) 159,906 0 38,852
Changes in stockholders' equity                
Dividends and dividend equivalents declared (55,291)              
Ending balance (in shares) at Dec. 31, 2024     61,215          
Ending balance at Dec. 31, 2024 793,136 765,247 $ 61 787,725 (140,315) 180,276 (62,500) 27,889
Changes in stockholders' equity                
Net income (loss) 99,184 99,372       99,372   (188)
Other comprehensive income (loss) 6,463 6,463     6,463      
Share-based compensation 6,941 6,941   6,941        
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (in shares)     247          
Vesting of restricted common stock, including impact of DERs, net of shares withheld for employee taxes (Note 11) (9,686) (9,686)   (9,686)        
Purchases of common stock (Note 10) (in shares)     (541)          
Purchases of common stock (Note 10) (36,840) (36,840)   (6,909)   (29,931)    
Share repurchase liability (Note 10) (36,637) (36,637)         (36,637)  
Dividends and dividend equivalents declared (14,576) (14,576)       (14,576)    
Deconsolidation of VIE (Note 1) (27,701)             (27,701)
Ending balance (in shares) at Mar. 31, 2025     60,921          
Ending balance at Mar. 31, 2025 $ 780,284 $ 780,284 $ 61 $ 778,071 $ (133,852) $ 235,141 $ (99,137) $ 0
v3.25.1
Summary of Significant Accounting Policies
 3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of Acushnet Holdings Corp. (the “Company”) have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). These unaudited condensed consolidated financial statements include the accounts of the Company and Acushnet Company, including its wholly-owned subsidiaries and less than wholly-owned subsidiaries, which include VIEs in which Acushnet Company is the primary beneficiary. In addition, investments in entities over which the Company has significant influence but not control are accounted for using the equity method of accounting. The Company conducts substantially all of its business through Acushnet Company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2025 are not necessarily indicative of results to be expected for the full year ending December 31, 2025, nor were those of the comparable 2024 periods representative of those actually experienced for the full year ended December 31, 2024. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2024 included in its Annual Report on Form 10-K filed with the SEC on February 27, 2025.
During the fourth quarter of 2024, the Company changed its accounting principle related to the presentation of costs associated with operating its distribution centers and costs associated with shipping and handling activities. The Company also changed its reportable segments during the fourth quarter of 2024. Prior period amounts have been updated to conform to the current year presentation for these changes.
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Variable Interest Entities
VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company presents separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of consolidated VIEs that can only be used to settle specific obligations of the consolidated VIEs and the liabilities of consolidated VIEs for which creditors do not have recourse to its general credit.
Prior to January 31, 2025, the Company consolidated the accounts of Acushnet Lionscore Limited (“Lionscore”), a VIE which is 40% owned by the Company. The sole purpose of Lionscore was to manufacture the Company’s footwear and as such, the Company was deemed to be the primary beneficiary. The general creditors of Lionscore do not have recourse to the Company. Certain directors of Lionscore had guaranteed the credit lines of Lionscore, for which there were no outstanding borrowings as of December 31, 2024. In addition, pursuant to the terms of the agreement governing Lionscore, the Company was not required to provide financial support to Lionscore.
During January 2025, Lionscore permanently ceased manufacturing at its Fujian Fuh Deh Leh (“FDL”) factory in Fuzhou, China and all footwear production volume was shifted to a third-party supplier in Vietnam affiliated with the Company's Lionscore joint venture partner. As a result, the Company is no longer the primary beneficiary of Lionscore and has deconsolidated the accounts of Lionscore effective as of January 31, 2025. As such, the unaudited condensed consolidated statement of operations for the three months ended March 31, 2025 included one month of activity related to Lionscore prior to the deconsolidation. As of March 31, 2025, the assets and liabilities of Lionscore were no longer included within the Company's unaudited condensed consolidated balance sheet. In addition, any retained equity interest or investment in the former subsidiary is measured at fair value as of the date of deconsolidation. The fair value of the Company's equity interest in Lionscore as of the date of deconsolidation, determined by the appraised value of Lionscore's operating assets, was $14.1 million. In connection with the deconsolidation of Lionscore, the Company recorded a non-cash gain on deconsolidation of $20.9 million during the three months ended March 31, 2025, which was included within other (income) expense, net on the unaudited condensed consolidated statement of operations. Subsequent to the deconsolidation, the Company accounted for its equity ownership interest in Lionscore under the equity method of accounting. See Note 16 for additional information regarding restructuring activities impacting Lionscore prior to deconsolidation.
Equity Method Investments
The Company uses the equity method of accounting for equity investments if the investment enables the Company to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in consolidated net income (loss). The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. An impairment that is other-than-temporary is recognized in the period identified.
For the three months ended March 31, 2025, the Company recorded a $0.2 million loss related to the Lionscore equity-method investment, which was included within other (income) expense, net on the unaudited condensed consolidated statement of operations. The carrying value of the Company's investment in Lionscore was $13.9 million as of March 31, 2025, which was included within other assets on the Company's unaudited condensed consolidated balance sheet. As of March 31, 2025, the Company had outstanding payables to Lionscore of $7.2 million, primarily associated with the purchase of footwear prior to the closure of Lionscore's production lines, which was included within accrued expenses and other liabilities on the Company's unaudited condensed consolidated balance sheet.
Noncontrolling Interests and Redeemable Noncontrolling Interests
The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.
Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The Company initially records the redeemable noncontrolling interest at its acquisition date fair value. The carrying amount of the redeemable noncontrolling interest is subsequently adjusted to the greater amount of either the initial carrying amount, increased or decreased for the redeemable noncontrolling interest's share of comprehensive income (loss) or the redemption value, assuming the noncontrolling interest is redeemable at the balance sheet date. This adjustment is recognized through retained earnings and is not reflected in net income (loss) or comprehensive income (loss). The value attributable to redeemable noncontrolling interests and any related loans to minority shareholders, which are recorded as a reduction to redeemable noncontrolling interests, are presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity. The amount of the loan to minority shareholders was $4.4 million as of both March 31, 2025 and December 31, 2024.
Cash, Cash Equivalents and Restricted Cash
Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations. As of March 31, 2025 and December 31, 2024, the amount of restricted cash included in cash, cash equivalents and restricted cash on the unaudited condensed consolidated balance sheets was $1.2 million and $1.6 million, respectively.
Foreign Currency Transactions
Foreign currency transaction gains (losses) included in selling, general and administrative expenses were gains of $1.4 million and losses of $0.1 million for the three months ended March 31, 2025 and 2024, respectively.
Recently Issued Accounting Standards
Income Taxes
In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures." The amendments in this update provide more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.
Expense Disaggregation Disclosures
In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)." The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.
v3.25.1
Allowance for Credit Losses
 3 Months Ended
Mar. 31, 2025
Receivables [Abstract]  
Allowance for Credit Losses Allowance for Credit Losses
The Company estimates expected credit losses using a number of factors, including customer credit ratings, age of receivables, historical credit loss information and current and forecasted economic conditions, which could affect the collectability of the reported amounts. All these factors have been considered in the estimate of expected credit losses for the periods presented.
The activity related to the allowance for credit losses was as follows:
Three months ended March 31,
(in thousands)20252024
Balance at beginning of period$7,238 $8,840 
(Decrease) increase in provision for expected credit losses(920)312 
Amount of receivables recovered (written off)91 (196)
Foreign currency translation124 (93)
Balance at end of period$6,533 $8,863 
v3.25.1
Inventories
 3 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
Inventories Inventories
The components of inventories were as follows: 
March 31,December 31,
(in thousands)20252024
Raw materials and supplies$131,842 $137,150 
Work-in-process29,978 33,549 
Finished goods376,321 405,265 
Inventories$538,141 $575,964 
v3.25.1
Product Warranty
 3 Months Ended
Mar. 31, 2025
Product Warranties Disclosures [Abstract]  
Product Warranty Product Warranty
The Company has defined warranties generally ranging from one to two years. Products covered by the defined warranty policies primarily include all Titleist golf products, FootJoy golf shoes and FootJoy golf outerwear. These product warranties generally obligate the Company to pay for the cost of replacement products, including the cost of shipping replacement products to its customers. The estimated cost of satisfying future warranty claims is accrued at the time the sale is recorded. In estimating future warranty obligations, the Company considers various factors, including its warranty policies and practices, the historical frequency of claims and the cost to replace or repair products under warranty.
The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:
 Three months ended March 31,
(in thousands)20252024
Balance at beginning of period$4,980 $4,997 
Provision1,441 1,537 
Claims paid/costs incurred(1,266)(1,296)
Foreign currency translation35 (56)
Balance at end of period$5,190 $5,182 
v3.25.1
Debt and Financing Arrangements
 3 Months Ended
Mar. 31, 2025
Debt Disclosure [Abstract]  
Debt and Financing Arrangements Debt and Financing Arrangements
Credit Facility
The Company's credit agreement, dated as of December 23, 2019 (as subsequently amended on July 3, 2020, August 2, 2022 and May 2, 2024 (the "Amended Credit Agreement")), provides for a $950.0 million multi-currency revolving credit facility, due to mature on August 2, 2027.
The Amended Credit Agreement contains customary affirmative and restrictive covenants, including, among others, financial covenants based on the Company's leverage and interest coverage ratios. The Amended Credit Agreement also includes customary events of default, the occurrence of which, following any applicable cure period, would permit the lenders to, among other things, declare the principal, accrued interest and other obligations to be immediately due and payable. As of March 31, 2025, the Company was in compliance with all covenants under its Amended Credit Agreement.
As of March 31, 2025 and December 31, 2024, there were $577.6 million and $404.7 million, respectively, in outstanding borrowings under the Company's multi-currency revolving credit facility, with a weighted average interest rate of 5.48% and 5.51%, respectively. As of March 31, 2025, the Company had available borrowings under its multi-currency revolving credit facility of $369.5 million after giving effect to $2.9 million of outstanding letters of credit.
Senior Unsecured Notes
As of March 31, 2025 and December 31, 2024, Acushnet Company had 7.375% senior unsecured notes due 2028 (the "Notes") outstanding in the aggregate principal balance of $350.0 million. The fair value of the Notes, based on third-party quotes (Level 2), as of March 31, 2025 and December 31, 2024 was $362.3 million and $362.1 million, respectively.
The Notes bear interest at a stated interest rate of 7.375% (an effective interest rate of 7.813%) per year, with interest payable semi-annually on April 15 and October 15 of each year. Accrued interest related to the Notes of $11.8 million and $5.6 million was included within accrued expenses and other liabilities on the unaudited condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024, respectively.
The indenture that governs the Notes (the "Indenture") contains covenants that, among other things, limit the ability of the Company and its restricted subsidiaries to incur additional debt or issue certain preferred stock; pay dividends or repurchase or redeem capital stock; prepay, redeem or repurchase certain debt; make loans and investments; sell assets; incur liens; enter into certain types of transactions with the Company’s affiliates; and consolidate or merge with or into other companies. As of March 31, 2025, the Company was in compliance with all covenants under the Indenture.
Other Short-Term Borrowings
The Company has certain unsecured local credit facilities available through its subsidiaries. Amounts outstanding under other short-term borrowings are presented in short-term debt in the unaudited condensed consolidated balance sheets with the proceeds and repayments presented on a gross basis in the unaudited condensed consolidated statements of cash flows. There were $17.3 million and $10.2 million in outstanding borrowings under the Company's local credit facilities as of March 31, 2025 and December 31, 2024, respectively. The weighted average interest rate applicable to the outstanding borrowings was 0.81% and 0.61% as of March 31, 2025 and December 31, 2024, respectively. As of March 31, 2025, the Company had available borrowings remaining under these local credit facilities of $38.6 million.
Letters of Credit
As of March 31, 2025 and December 31, 2024, there were outstanding letters of credit related to agreements, including the Amended Credit Agreement, totaling $5.9 million and $5.7 million, respectively, of which $2.9 million was secured as of both March 31, 2025 and December 31, 2024. These agreements provided a maximum commitment for letters of credit of $58.8 million as of March 31, 2025.
v3.25.1
Derivative Financial Instruments
 3 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
The Company principally uses derivative financial instruments to reduce the impact of foreign currency fluctuations and interest rate variability on the Company's results of operations. The principal derivative financial instruments the Company enters into are foreign exchange forward contracts and interest rate swaps. The Company does not enter into derivative financial instrument contracts for trading or speculative purposes.
Foreign Exchange Derivative Instruments
Foreign exchange forward contracts are foreign exchange derivative instruments primarily used to reduce foreign currency risk related to transactions denominated in a currency other than functional currency. These instruments are designated as cash flow hedges. The periods of the foreign exchange forward contracts correspond to the periods of the hedged forecasted transactions, which do not exceed 24 months subsequent to the latest balance sheet date. The primary foreign exchange forward contracts pertain to the U.S. dollar, the Japanese yen, the British pound sterling, the Canadian dollar, the Korean won, the Australian dollar and the euro. The gross U.S. dollar equivalent notional amount outstanding of all foreign exchange forward contracts designated under hedge accounting as of March 31, 2025 and December 31, 2024 was $206.2 million and $192.2 million, respectively.
Interest Rate Derivative Instruments
From time to time, the Company enters into interest rate swap contracts to reduce interest rate risk related to floating rate debt. Under the contracts, the Company pays fixed and receives variable rate interest, in effect converting a portion of its floating rate debt to fixed rate debt. Interest rate swap contracts are accounted for as cash flow hedges. As of March 31, 2025, there were no outstanding interest rate swap contracts. As of December 31, 2024, the notional value of the Company's outstanding interest rate swap contracts was $100.0 million.
Impact on Financial Statements
The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:
(in thousands)March 31,December 31,
Balance Sheet LocationHedge Instrument Type20252024
Prepaid and other assetsForeign exchange forward$3,968 $8,135 
Interest rate swap— 4 
Accrued expenses and other liabilitiesForeign exchange forward1,704 251 
Interest rate swap— 1 
The hedge instrument (losses) gains recognized in accumulated other comprehensive loss, net of tax was as follows:
 Three months ended
 March 31,
(in thousands)20252024
Type of hedge  
Foreign exchange forward$(2,160)$3,342 
Interest rate swap — 579 
 Total$(2,160)$3,921 
Gains and losses on derivative instruments designated as cash flow hedges are reclassified from accumulated other comprehensive loss, net of tax at the time the forecasted hedged transaction impacts the statements of operations or at the time the hedge is determined to be ineffective. Based on the current valuation, during the next 12 months the Company expects to reclassify a net gain of $4.6 million related to foreign exchange derivative instruments from accumulated other comprehensive loss, net of tax, into cost of goods sold. For further information related to amounts recognized in accumulated other comprehensive loss, net of tax, see Note 12.
The hedge instrument (losses) gains recognized on the unaudited condensed consolidated statements of operations were as follows:
 Three months ended
 March 31,
(in thousands)20252024
Location of (losses) gains in statements of operations  
Foreign exchange forward:
Cost of goods sold$411 $2,738 
Selling, general and administrative (1)
(960)723 
Total $(549)$3,461 
Interest Rate Swap:
Interest expense, net$3 $260 
Total$3 $260 
_______________________________________________________________________________
(1)    Relates to net (losses) gains on foreign exchange forward contracts derived from previously designated cash flow hedges.
Credit Risk
The Company enters into derivative contracts with major financial institutions with investment grade credit ratings and is exposed to credit losses in the event of non-performance by these financial institutions. This credit risk is generally limited to the unrealized gains in the derivative contracts. However, the Company monitors the credit quality of these financial institutions, as well as its own credit quality, and considers the risk of counterparty default to be minimal.
v3.25.1
Fair Value Measurements
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Certain assets and liabilities are carried at fair value under U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2025 were as follows:
 Fair Value Measurements as of 
 March 31, 2025 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$2,520 $— $— Prepaid and other assets
Foreign exchange derivative instruments— 3,968 — Prepaid and other assets
Deferred compensation program assets600 — — Other assets
Total assets$3,120 $3,968 $—  
Liabilities    
Foreign exchange derivative instruments$— $1,704 $— Accrued expenses and other liabilities
Deferred compensation program liabilities600 — — Other noncurrent liabilities
Total liabilities$600 $1,704 $—  
Assets and liabilities measured at fair value on a recurring basis as of December 31, 2024 were as follows:
 Fair Value Measurements as of 
 December 31, 2024 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$3,150 $— $— Prepaid and other assets
Foreign exchange derivative instruments— 8,135 — Prepaid and other assets
Interest rate derivative instruments— 4 — Prepaid and other assets
Deferred compensation program assets633 — — Other assets
Total assets$3,783 $8,139 $—  
Liabilities    
Foreign exchange derivative instruments$— $251 $— Accrued expenses and other liabilities
Interest rate derivative instruments— 1 — Accrued expenses and other liabilities
Deferred compensation program liabilities633 — — Other noncurrent liabilities
Total liabilities$633 $252 $—  
Rabbi trust assets are used to fund certain retirement obligations of the Company. The assets underlying the Rabbi trust are equity and fixed income exchange-traded funds.
Deferred compensation program assets and liabilities represent a program where select employees could defer compensation until termination of employment. Effective July 29, 2011, this program was amended to cease all employee compensation deferrals and provided for the distribution of all previously deferred employee compensation. The program remains in effect with respect to the value attributable to the employer match contributed prior to July 29, 2011.
Foreign exchange derivative instruments are foreign exchange forward contracts primarily used to limit currency risk that would otherwise result from changes in foreign exchange rates (Note 6). The Company uses the mid-price of foreign exchange forward rates as of the close of business on the valuation date to value each foreign exchange forward contract at each reporting period.
Interest rate derivative instruments are interest rate swap contracts used to reduce interest rate risk related to the Company's floating rate debt (Note 6). The valuation for the interest rate swap is calculated as the net of the discounted future cash flows of the pay and receive legs of the swap. Mid-market interest rates on the valuation date are used to create the forward curve for floating legs and discount curve.
v3.25.1
Pension and Other Postretirement Benefits
 3 Months Ended
Mar. 31, 2025
Retirement Benefits [Abstract]  
Pension and Other Postretirement Benefits Pension and Other Postretirement Benefits
Components of net periodic benefit cost (credit) were as follows: 
 Pension BenefitsPostretirement Benefits
 Three months ended March 31,
(in thousands)2025202420252024
Components of net periodic benefit cost (credit)    
Service cost$1,279 $1,325 $90 $91 
Interest cost2,892 2,703 143 133 
Expected return on plan assets(2,017)(1,838)— — 
Amortization of net loss (gain)67 58 (237)(269)
Amortization of prior service cost (credit)22 23 (1)(34)
Net periodic benefit cost (credit)$2,243 $2,271 $(5)$(79)
The non-service cost components of net periodic benefit cost (credit) are included in other (income) expense, net in the unaudited condensed consolidated statements of operations.
v3.25.1
Income Taxes
 3 Months Ended
Mar. 31, 2025
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Income tax expense decreased by $1.8 million to $21.6 million for the three months ended March 31, 2025 compared to $23.4 million for the three months ended March 31, 2024. The Company’s effective income tax rate ("ETR") was 17.9% for the three months ended March 31, 2025 compared to 21.7% for the three months ended March 31, 2024.
The ETR for the three months ended March 31, 2025 differed from the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income and federal and state tax credits, partially offset by the U.S. taxation of foreign income, state income taxes and the Company's jurisdictional mix of earnings. The ETR for the three months ended March 31, 2024 differed from the U.S. statutory tax rate primarily due to the U.S. taxation of foreign income, state income taxes and the Company's jurisdictional mix of earnings, partially offset by the impact of the U.S. deduction for foreign-derived intangible income and federal and state tax credits.
v3.25.1
Common Stock
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Common Stock Common Stock
Dividends
The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:
Dividends per Common Share
Amount
(in thousands)
2025:
First Quarter$0.235 $14,576 
Total dividends declared in 2025$0.235 $14,576 
2024:
Fourth Quarter$0.215 $13,476 
Third Quarter0.215 13,787 
Second Quarter0.215 13,873 
First Quarter0.215 14,155 
Total dividends declared in 2024$0.860 $55,291 
During the second quarter of 2025, the Company's board of directors declared a dividend of $0.235 per share of common stock to shareholders of record as of June 6, 2025 and payable on June 20, 2025.
Share Repurchase Program
As of March 31, 2025, the board of directors had authorized the Company to repurchase up to $1.25 billion of its issued and outstanding common stock since the share repurchase program was established in 2018. Share repurchases may be effected from time to time in open market or privately negotiated transactions, including transactions with affiliates, with the timing of purchases and the amount of stock purchased generally determined at the discretion of the Company consistent with the Company's general working capital needs and within the constraints of the Amended Credit Agreement and the Indenture (Note 5). This program may be extended or otherwise modified by the board of directors at any time and will remain in effect until completed or until terminated by the board of directors.
On March 14, 2024, the Company entered into an agreement with Magnus Holdings Co., Ltd. ("Magnus"), to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from April 1, 2024 through June 28, 2024, up to an aggregate of $37.5 million, at the same weighted average per share price (the "March 2024 Agreement"). On July 10, 2024, the Company purchased 587,520 shares of its common stock from Magnus for an aggregate of $37.5 million in satisfaction of its obligation under the March 2024 Agreement.
On June 14, 2024, the Company entered into an agreement with Magnus to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from July 1, 2024 through December 31, 2024, up to an aggregate of $62.5 million, at the same weighted average per share price (the "June 2024 Agreement"). In relation to this agreement, the Company recognized a share repurchase liability of $62.5 million for 935,907 shares of common stock, which was included in accrued expenses and other liabilities and treasury stock on the unaudited condensed consolidated balance sheets as of March 31, 2025 and December 31, 2024.
On December 17, 2024, the Company entered into an agreement with Magnus to purchase from Magnus an equal amount of its common stock as it purchases on the open market over the period of time from January 2, 2025 through June 30, 2025, up to an aggregate of $62.5 million, at the same weighted average per share price (the "December 2024 Agreement"). In relation to this agreement, the Company recognized an additional share repurchase liability of $36.6 million for 540,944 shares of common stock, bringing the total share repurchase liability included in accrued expenses and other liabilities and treasury stock on the unaudited condensed consolidated balance sheet as of March 31, 2025 to $99.1 million for 1,476,851 shares.
The Company's share repurchase activity for the periods presented was as follows:
Three months ended March 31,
(in thousands, except share and per share amounts)20252024
Shares repurchased in the open market:
Shares repurchased 540,944 547,233 
Average price$67.73 $64.51 
Aggregate value (1)
$36,637 $35,302 
Total shares repurchased:
Shares repurchased540,944 547,233 
Average price$67.73 $64.51 
Aggregate value$36,637 $35,302 
___________________________________
(1) Includes $1.0 million and $2.0 million related to shares repurchased not settled as of the three months ended March 31, 2025 and 2024, respectively.

As of March 31, 2025, the Company had $415.5 million remaining under the current share repurchase authorization, of which $62.5 million was utilized by the Company on April 10, 2025, to repurchase 935,907 shares of its common stock from Magnus in satisfaction of its obligations under the June 2024 Agreement.
Common Stock Retirement
The Company records retirements of repurchased common stock, upon either formal or constructive retirement, at cost and allocates the excess of the repurchase price over the par value of shares acquired to both retained earnings and additional paid-in capital. The portion allocated to additional paid-in capital is calculated on a pro rata basis of the shares to be retired and the total shares issued and outstanding as of the date of retirement. When shares of common stock are retired, they are deducted from the number of shares issued.
As of March 31, 2025, the Company presented as retired 540,944 shares of its repurchased common stock with an aggregate value of $36.6 million, including $0.2 million of excise tax on the shares repurchased, which the company intends to formally retire in 2025.
v3.25.1
Equity Incentive Plans
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plans Equity Incentive Plans
Under the Acushnet Holdings Corp. 2015 Omnibus Incentive Plan (the “2015 Plan”), the Company may grant stock options, stock appreciation rights, restricted shares of common stock, restricted stock units ("RSUs"), performance stock units ("PSUs") and other share-based and cash-based awards to members of the board of directors, officers, employees, consultants and advisors of the Company. As of March 31, 2025, the only equity-based awards granted under the 2015 Plan were RSUs and PSUs.
Restricted Stock and Performance Stock Units
RSUs granted to members of the board of directors vest immediately into shares of common stock. RSUs granted to Company officers generally vest over three years, with one-third of each grant vesting annually, subject to the recipient's continued employment with the Company. RSUs granted to other employees, consultants and advisors of the Company vest in accordance with the terms of the grants, generally either over three years or, beginning in 2022, with one-third of each grant vesting annually, subject to the recipient’s continued service to the Company. PSUs granted to Company officers and other employees vest based upon the Company's performance against specified targets, generally over a three-year performance period, subject to the recipient's continued service to the Company. At the end of the performance period, the number of shares of common stock that could be issued is determined based upon the Company's performance against these targets. The number of shares that could be issued can range from 0% to 200% of the recipient's target award. Recipients of the awards granted under the 2015 Plan may elect to defer receipt of all or any portion of any shares of common stock issuable upon vesting to a future date elected by the recipient.
All RSUs and PSUs granted under the 2015 Plan have DERs, which entitle holders of RSUs and PSUs to the same dividend value per share as holders of common stock and can be paid in either cash or common stock. DERs are subject to the same vesting and other terms and conditions as the corresponding RSUs and PSUs. DERs are paid when the underlying shares of common stock are delivered.
A summary of the Company’s RSUs and PSUs as of March 31, 2025 and changes during the three months then ended is presented below: 
 Weighted-Weighted-
 NumberAverageNumberAverage
 of RSUsFair Value RSUs
of PSUs (3)
Fair Value PSUs
Outstanding as of December 31, 2024668,030 $56.40 500,967 $52.66 
Granted309,497 68.21 165,248 68.21 
Vested (1)(2)
(310,309)52.77 (151,848)43.96 
Forfeited(1,583)59.94 (528)59.95 
Outstanding as of March 31, 2025665,635 $63.58 513,839 $60.23 

_______________________________________________________________________________
(1)    Includes 36,934 shares of common stock related to RSUs that were not delivered as of March 31, 2025.
(2)    Based upon the Company’s level of achievement of the applicable performance metrics, the recipients of the 151,848 PSUs that vested during the three months ended March 31, 2025, were entitled to receive 196,795 shares of common stock. As of March 31, 2025, there were 75,693 shares of common stock that had not been delivered in connection with the vesting of these PSUs.
(3)    Number of PSUs reflects 100% of the target level grant and may not be indicative of the performance level expected to be achieved.
Compensation expense recorded related to the Company's RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20252024
RSUs$5,032 $4,496 
PSUs1,909 2,764 
The remaining unrecognized compensation expense related to unvested RSUs and unvested PSUs was $37.3 million and $20.6 million, respectively, as of March 31, 2025, and is expected to be recognized over the related weighted average period of 1.6 years and 2.2 years, respectively.
A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below:
Three months endedThree months ended
 March 31, 2025March 31, 2024
RSUsPSUsRSUsPSUs
Shares of common stock issued273,390 121,102 418,829 219,831 
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations
(93,949)(53,209)(137,107)(95,814)
Net shares of common stock issued179,441 67,893 281,722 124,017 
Cumulative undelivered shares of common stock517,542 546,789 485,027 471,078 
Compensation Expense
The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20252024
Cost of goods sold$473 $429 
Selling, general and administrative6,070 6,563 
Research and development398 432 
Total compensation expense before income tax6,941 7,424 
Income tax benefit1,407 1,672 
Total compensation expense, net of income tax$5,534 $5,752 
v3.25.1
Accumulated Other Comprehensive Loss, Net of Tax
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Accumulated Other Comprehensive Loss, Net of Tax Accumulated Other Comprehensive Loss, Net of Tax
Accumulated other comprehensive loss, net of tax consists of foreign currency translation adjustments, unrealized gains and losses from derivative instruments designated as cash flow hedges (Note 6) and pension and other postretirement adjustments (Note 8).
The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows:
 ForeignInterestAccumulated
 ForeignExchangeRate SwapPension andOther
CurrencyDerivativeDerivativeOtherComprehensive
(in thousands)TranslationInstrumentsInstrumentsPostretirementLoss, Net of Tax
Balance as of December 31, 2024$(123,497)$4,772 $2 $(21,592)$(140,315)
Other comprehensive income (loss) before reclassifications8,798 (2,160)— (478)6,160 
Amounts reclassified from accumulated other comprehensive loss, net of tax— (411)(3)(149)(563)
Tax benefit — 738 1 127 866 
Balance as of March 31, 2025$(114,699)$2,939 $— $(22,092)$(133,852)
v3.25.1
Net Income per Common Share
 3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Net Income per Common Share Net Income per Common Share
The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:
 Three months ended
 March 31,
(in thousands, except share and per share amounts)20252024
Net income attributable to Acushnet Holdings Corp.$99,372 $87,762 
Weighted average number of common shares:
Basic61,325,623 64,621,122 
RSUs159,165 268,052 
Diluted61,484,788 64,889,174 
Net income per common share attributable to Acushnet Holdings Corp.:
Basic$1.62 $1.36 
Diluted$1.62 $1.35 
Net income per common share attributable to Acushnet Holdings Corp. was calculated using the treasury stock method.
The Company’s potential dilutive securities for the three months ended March 31, 2025 and 2024 include RSUs and PSUs. PSUs vest based upon achievement of performance targets and are excluded from the diluted shares outstanding unless the performance targets have been met as of the end of the applicable reporting period regardless of whether such performance targets are probable of achievement.
The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:
 Three months ended
 March 31,
 20252024
RSUs248,808 223,717 
v3.25.1
Segment Information
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company’s operating segments are based on how the Chief Operating Decision Maker ("CODM"), the Company's President and Chief Executive Officer, makes decisions about assessing performance and allocating resources. The Company currently has three reportable segments: (i) Titleist golf equipment, (ii) FootJoy golf wear and (iii) Golf gear.
The CODM primarily uses segment operating income (loss) to evaluate the effectiveness of business strategies, assess segment operating performance and make decisions regarding costs to incur across the business. Segment operating income (loss) includes directly attributable expenses and certain shared costs of corporate administration that are allocated to the operating segments, but excludes certain other costs, such as interest expense, net; restructuring costs; the non-service cost component of net periodic benefit cost; transaction fees; as well as other items that are not allocated to the reportable segments. The CODM does not evaluate a measure of assets when assessing performance.
Results shown for the three months ended March 31, 2025 and 2024 are not necessarily those which would be achieved if each segment was an unaffiliated business enterprise. There are no intersegment transactions.
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31, 2025
(in thousands)Titleist Golf EquipmentFootJoy Golf WearGolf GearTotal Reportable Segments
Other (1)
Total Consolidated
Net sales$421,092 $178,436 $70,963 $670,491 $32,881 $703,372 
Segment expenses:
Cost of goods sold206,524 104,232 40,824 351,580 
Advertising and promotion44,659 13,397 3,401 61,457 
Research and development16,344 1,310 675 18,329 
Selling, general and administrative75,269 34,927 11,649 121,845 
Other segment items (2)
2,448 55 648 3,151 
Other expenses— — — — 32,463 
Total operating income 75,848 24,515 13,766 114,129 418 114,547 
Reconciling items:
Interest expense, net(13,815)
Non-service cost component of net periodic benefit cost(869)
Other (3)
20,732 
Total income before income tax$120,595 
_________________________________
(1) Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.
(2) Other segment items primarily includes identifiable intangible asset amortization expense.
(3) Other includes a non-cash gain on deconsolidation of $20.9 million related to Lionscore (Note 1).
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31, 2024
(in thousands)Titleist Golf EquipmentFootJoy Golf WearGolf GearTotal Reportable Segments
Other (1)
Total Consolidated
Net sales$411,873 $191,066 $69,513 $672,452 $35,102 $707,554 
Segment expenses:
Cost of goods sold192,132 112,940 43,956 349,028 
Advertising and promotion39,341 13,662 3,058 56,061 
Research and development14,382 1,035 595 16,012 
Selling, general and administrative71,804 36,448 11,629 119,881 
Other segment items (2)
2,451 55 649 3,155 
Restructuring costs (Note 16)
— — — — 6,967 
Other expenses— — — — 35,069 
Total operating income (loss)91,763 26,926 9,626 128,315 (6,934)121,381 
Reconciling items:
Interest expense, net(13,076)
Non-service cost component of net periodic benefit cost(776)
Other437 
Total income before income tax$107,966 
_________________________________
(1) Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.
(2) Other segment items primarily includes identifiable intangible asset amortization expense.
Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates.
Three months ended March 31,
(in thousands)20252024
United States$424,209 $418,243 
EMEA (1)
103,869 101,679 
Japan35,232 37,150 
Korea66,218 75,251 
Rest of World73,844 75,231 
Total net sales$703,372 $707,554 
_______________________________________________________________________________
(1) Europe, the Middle East and Africa ("EMEA")
v3.25.1
Commitments and Contingencies
 3 Months Ended
Mar. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Litigation
The Company and its subsidiaries are party to lawsuits associated with the normal conduct of their businesses and operations. It is not possible to predict the outcome of the pending actions, and, as with any litigation, it is possible that some of these actions could be decided unfavorably. Consequently, the Company is unable to estimate the ultimate aggregate amount of monetary loss, amounts covered by insurance or the financial impact that will result from such matters and has not recorded a liability related to potential losses.
v3.25.1
Restructuring Costs
 3 Months Ended
Mar. 31, 2025
Restructuring and Related Activities [Abstract]  
Restructuring Costs Restructuring Costs
During the first quarter of 2024, Lionscore approved a plan to permanently close certain production lines at its FDL factory in Fuzhou, China and involuntarily separate certain direct and indirect manufacturing employees, as footwear production volume was shifted to a third-party supplier in Vietnam affiliated with the Company's Lionscore joint venture partner. The remaining direct and indirect manufacturing employees at the FDL factory continued to service the remaining production lines. During the fourth quarter of 2024, Lionscore approved an additional plan to permanently cease manufacturing at the FDL factory, including all remaining production lines, in the first quarter of 2025 and to shift the remaining footwear production volume to the aforementioned third-party supplier in Vietnam. As a result, Lionscore involuntarily separated substantially all of the remaining employees of the FDL factory during the first quarter of 2025.
The activity related to these plans was as follows:
(in thousands)Three months ended March 31,
20252024
Balance at beginning of period$12,431 $— 
Provision— 6,967 
Payments(5,439)(4,720)
Deconsolidation of VIE (Note 1)
(6,992)— 
Balance at end of period$— $2,247 
The provision for involuntary employee termination costs associated with these plans was included in selling, general and administrative on the unaudited condensed consolidated statement of operations. There are no further costs expected to be incurred in relation to these restructuring plans. The liabilities for involuntary employee termination costs associated with these plans were included within accrued expenses and other liabilities on the unaudited condensed consolidated balance sheet as of December 31, 2024. See Note 1 for further information.
v3.25.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Pay vs Performance Disclosure    
Net income attributable to Acushnet Holdings Corp. $ 99,372 $ 87,762
v3.25.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2025
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.1
Summary of Significant Accounting Policies (Policies)
 3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements of Acushnet Holdings Corp. (the “Company”) have been prepared in conformity with accounting principles generally accepted in the United States (“U.S. GAAP”). These unaudited condensed consolidated financial statements include the accounts of the Company and Acushnet Company, including its wholly-owned subsidiaries and less than wholly-owned subsidiaries, which include VIEs in which Acushnet Company is the primary beneficiary. In addition, investments in entities over which the Company has significant influence but not control are accounted for using the equity method of accounting. The Company conducts substantially all of its business through Acushnet Company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Certain information in footnote disclosures normally included in annual financial statements has been condensed or omitted for the interim periods presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) and U.S. GAAP. The year-end balance sheet data was derived from audited financial statements; however, the accompanying interim notes to the unaudited condensed consolidated financial statements do not include all disclosures required by U.S. GAAP. In the opinion of management, the financial statements contain all normal and recurring adjustments necessary to state fairly the financial position and results of operations of the Company. The results of operations for the three months ended March 31, 2025 are not necessarily indicative of results to be expected for the full year ending December 31, 2025, nor were those of the comparable 2024 periods representative of those actually experienced for the full year ended December 31, 2024. These unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and related notes for the fiscal year ended December 31, 2024 included in its Annual Report on Form 10-K filed with the SEC on February 27, 2025.
During the fourth quarter of 2024, the Company changed its accounting principle related to the presentation of costs associated with operating its distribution centers and costs associated with shipping and handling activities. The Company also changed its reportable segments during the fourth quarter of 2024. Prior period amounts have been updated to conform to the current year presentation for these changes.
Use of Estimates
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts of assets and liabilities and related disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates.
Variable Interest Entities
Variable Interest Entities
VIEs are entities that, by design, either (i) lack sufficient equity to permit the entity to finance its activities independently, or (ii) have equity holders that do not have the power to direct the activities of the entity that most significantly impact its economic performance, the obligation to absorb the entity’s expected losses, or the right to receive the entity’s expected residual returns. The Company consolidates a VIE when it is the primary beneficiary, which is the party that has both (i) the power to direct the activities that most significantly impact the VIE’s economic performance and (ii) through its interests in the VIE, the obligation to absorb expected losses or the right to receive expected benefits from the VIE that could potentially be significant to the VIE. The Company presents separately on its unaudited condensed consolidated balance sheets, to the extent material, the assets of consolidated VIEs that can only be used to settle specific obligations of the consolidated VIEs and the liabilities of consolidated VIEs for which creditors do not have recourse to its general credit.
Equity Method Investments
Equity Method Investments
The Company uses the equity method of accounting for equity investments if the investment enables the Company to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in consolidated net income (loss). The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. An impairment that is other-than-temporary is recognized in the period identified.
Noncontrolling Interests and Redeemable Noncontrolling Interests
Noncontrolling Interests and Redeemable Noncontrolling Interests
The ownership interests held by owners other than the Company in less than wholly-owned subsidiaries are classified as noncontrolling interests. The financial results and position of noncontrolling interests are included in the Company’s unaudited condensed consolidated financial statements. The value attributable to the noncontrolling interests is presented on the unaudited condensed consolidated balance sheets, separately from the equity attributable to the Company. Net income (loss) and comprehensive income (loss) attributable to noncontrolling interests are presented separately on the unaudited condensed consolidated statements of operations and unaudited condensed consolidated statements of comprehensive income, respectively.
Redeemable noncontrolling interests are those noncontrolling interests which are or may become redeemable at a fixed or determinable price on a fixed or determinable date, at the option of the holder, or upon occurrence of an event. The Company initially records the redeemable noncontrolling interest at its acquisition date fair value. The carrying amount of the redeemable noncontrolling interest is subsequently adjusted to the greater amount of either the initial carrying amount, increased or decreased for the redeemable noncontrolling interest's share of comprehensive income (loss) or the redemption value, assuming the noncontrolling interest is redeemable at the balance sheet date. This adjustment is recognized through retained earnings and is not reflected in net income (loss) or comprehensive income (loss). The value attributable to redeemable noncontrolling interests and any related loans to minority shareholders, which are recorded as a reduction to redeemable noncontrolling interests, are presented in the unaudited condensed consolidated balance sheets as temporary equity between liabilities and shareholders’ equity.
Cash, Cash Equivalents and Restricted Cash
Cash, Cash Equivalents and Restricted Cash
Cash held in Company checking accounts is included in cash. Cash equivalents consist of short-term highly liquid investments with original maturities of three months or less which are readily convertible into cash. The Company classifies as restricted certain cash that is not available for use in its operations.
Foreign Currency Transactions
Foreign Currency Transactions
Foreign currency transaction gains (losses) included in selling, general and administrative expenses were gains of $1.4 million and losses of $0.1 million for the three months ended March 31, 2025 and 2024, respectively.
Recently Issued Accounting Standards
Recently Issued Accounting Standards
Income Taxes
In December 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-09, "Income Taxes (Topic 740) - Improvements to Income Tax Disclosures." The amendments in this update provide more transparency about income tax information through improvements to income tax disclosures primarily related to the rate reconciliation and income taxes paid information. ASU 2023-09 is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.
Expense Disaggregation Disclosures
In November 2024, the FASB issued ASU 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)." The amendments in this update require disclosure, in the notes to financial statements, of specified information about certain costs and expenses. ASU 2024-03 is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact this standard will have on its consolidated financial statements and related disclosures.
v3.25.1
Allowance for Credit Losses (Tables)
 3 Months Ended
Mar. 31, 2025
Receivables [Abstract]  
Schedule of Activity Related to the Allowance for Doubtful Accounts
The activity related to the allowance for credit losses was as follows:
Three months ended March 31,
(in thousands)20252024
Balance at beginning of period$7,238 $8,840 
(Decrease) increase in provision for expected credit losses(920)312 
Amount of receivables recovered (written off)91 (196)
Foreign currency translation124 (93)
Balance at end of period$6,533 $8,863 
v3.25.1
Inventories (Tables)
 3 Months Ended
Mar. 31, 2025
Inventory Disclosure [Abstract]  
Schedule of Inventories
The components of inventories were as follows: 
March 31,December 31,
(in thousands)20252024
Raw materials and supplies$131,842 $137,150 
Work-in-process29,978 33,549 
Finished goods376,321 405,265 
Inventories$538,141 $575,964 
v3.25.1
Product Warranty (Tables)
 3 Months Ended
Mar. 31, 2025
Product Warranties Disclosures [Abstract]  
Schedule of Warranty Obligation for Accrued Warranty Expense
The activity related to the Company’s warranty obligation for accrued warranty expense was as follows:
 Three months ended March 31,
(in thousands)20252024
Balance at beginning of period$4,980 $4,997 
Provision1,441 1,537 
Claims paid/costs incurred(1,266)(1,296)
Foreign currency translation35 (56)
Balance at end of period$5,190 $5,182 
v3.25.1
Derivative Financial Instruments (Tables)
 3 Months Ended
Mar. 31, 2025
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets
The fair value of hedge instruments recognized on the unaudited condensed consolidated balance sheets was as follows:
(in thousands)March 31,December 31,
Balance Sheet LocationHedge Instrument Type20252024
Prepaid and other assetsForeign exchange forward$3,968 $8,135 
Interest rate swap— 4 
Accrued expenses and other liabilitiesForeign exchange forward1,704 251 
Interest rate swap— 1 
Schedule of Effect of Hedge Instruments Losses on Accumulated Other Comprehensive Loss, Net of Tax
The hedge instrument (losses) gains recognized in accumulated other comprehensive loss, net of tax was as follows:
 Three months ended
 March 31,
(in thousands)20252024
Type of hedge  
Foreign exchange forward$(2,160)$3,342 
Interest rate swap — 579 
 Total$(2,160)$3,921 
Schedule of Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations
The hedge instrument (losses) gains recognized on the unaudited condensed consolidated statements of operations were as follows:
 Three months ended
 March 31,
(in thousands)20252024
Location of (losses) gains in statements of operations  
Foreign exchange forward:
Cost of goods sold$411 $2,738 
Selling, general and administrative (1)
(960)723 
Total $(549)$3,461 
Interest Rate Swap:
Interest expense, net$3 $260 
Total$3 $260 
_______________________________________________________________________________
(1)    Relates to net (losses) gains on foreign exchange forward contracts derived from previously designated cash flow hedges.
v3.25.1
Fair Value Measurements (Tables)
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis as of March 31, 2025 were as follows:
 Fair Value Measurements as of 
 March 31, 2025 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$2,520 $— $— Prepaid and other assets
Foreign exchange derivative instruments— 3,968 — Prepaid and other assets
Deferred compensation program assets600 — — Other assets
Total assets$3,120 $3,968 $—  
Liabilities    
Foreign exchange derivative instruments$— $1,704 $— Accrued expenses and other liabilities
Deferred compensation program liabilities600 — — Other noncurrent liabilities
Total liabilities$600 $1,704 $—  
Assets and liabilities measured at fair value on a recurring basis as of December 31, 2024 were as follows:
 Fair Value Measurements as of 
 December 31, 2024 using: 
(in thousands)Level 1Level 2Level 3Balance Sheet Location
Assets    
Rabbi trust$3,150 $— $— Prepaid and other assets
Foreign exchange derivative instruments— 8,135 — Prepaid and other assets
Interest rate derivative instruments— 4 — Prepaid and other assets
Deferred compensation program assets633 — — Other assets
Total assets$3,783 $8,139 $—  
Liabilities    
Foreign exchange derivative instruments$— $251 $— Accrued expenses and other liabilities
Interest rate derivative instruments— 1 — Accrued expenses and other liabilities
Deferred compensation program liabilities633 — — Other noncurrent liabilities
Total liabilities$633 $252 $—  
v3.25.1
Pension and Other Postretirement Benefits (Tables)
 3 Months Ended
Mar. 31, 2025
Retirement Benefits [Abstract]  
Schedule of Components of Net Periodic Benefit Cost (Credit)
Components of net periodic benefit cost (credit) were as follows: 
 Pension BenefitsPostretirement Benefits
 Three months ended March 31,
(in thousands)2025202420252024
Components of net periodic benefit cost (credit)    
Service cost$1,279 $1,325 $90 $91 
Interest cost2,892 2,703 143 133 
Expected return on plan assets(2,017)(1,838)— — 
Amortization of net loss (gain)67 58 (237)(269)
Amortization of prior service cost (credit)22 23 (1)(34)
Net periodic benefit cost (credit)$2,243 $2,271 $(5)$(79)
v3.25.1
Common Stock (Tables)
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Declared Dividends Per Share
The Company declared dividends per common share, including DERs (Note 11), during the periods presented as follows:
Dividends per Common Share
Amount
(in thousands)
2025:
First Quarter$0.235 $14,576 
Total dividends declared in 2025$0.235 $14,576 
2024:
Fourth Quarter$0.215 $13,476 
Third Quarter0.215 13,787 
Second Quarter0.215 13,873 
First Quarter0.215 14,155 
Total dividends declared in 2024$0.860 $55,291 
Schedule of Share Repurchase Activity
The Company's share repurchase activity for the periods presented was as follows:
Three months ended March 31,
(in thousands, except share and per share amounts)20252024
Shares repurchased in the open market:
Shares repurchased 540,944 547,233 
Average price$67.73 $64.51 
Aggregate value (1)
$36,637 $35,302 
Total shares repurchased:
Shares repurchased540,944 547,233 
Average price$67.73 $64.51 
Aggregate value$36,637 $35,302 
___________________________________
(1) Includes $1.0 million and $2.0 million related to shares repurchased not settled as of the three months ended March 31, 2025 and 2024, respectively.
v3.25.1
Equity Incentive Plans (Tables)
 3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Restricted and Performance Stock Units
A summary of the Company’s RSUs and PSUs as of March 31, 2025 and changes during the three months then ended is presented below: 
 Weighted-Weighted-
 NumberAverageNumberAverage
 of RSUsFair Value RSUs
of PSUs (3)
Fair Value PSUs
Outstanding as of December 31, 2024668,030 $56.40 500,967 $52.66 
Granted309,497 68.21 165,248 68.21 
Vested (1)(2)
(310,309)52.77 (151,848)43.96 
Forfeited(1,583)59.94 (528)59.95 
Outstanding as of March 31, 2025665,635 $63.58 513,839 $60.23 

_______________________________________________________________________________
(1)    Includes 36,934 shares of common stock related to RSUs that were not delivered as of March 31, 2025.
(2)    Based upon the Company’s level of achievement of the applicable performance metrics, the recipients of the 151,848 PSUs that vested during the three months ended March 31, 2025, were entitled to receive 196,795 shares of common stock. As of March 31, 2025, there were 75,693 shares of common stock that had not been delivered in connection with the vesting of these PSUs.
(3)    Number of PSUs reflects 100% of the target level grant and may not be indicative of the performance level expected to be achieved.
Schedule of Shares of Common Stock Issued
Compensation expense recorded related to the Company's RSUs and PSUs in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20252024
RSUs$5,032 $4,496 
PSUs1,909 2,764 
A summary of shares of common stock issued related to the 2015 Plan, including the impact of any DERs issued in common stock, is presented below:
Three months endedThree months ended
 March 31, 2025March 31, 2024
RSUsPSUsRSUsPSUs
Shares of common stock issued273,390 121,102 418,829 219,831 
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations
(93,949)(53,209)(137,107)(95,814)
Net shares of common stock issued179,441 67,893 281,722 124,017 
Cumulative undelivered shares of common stock517,542 546,789 485,027 471,078 
Schedule of Compensation Expense Related to Equity Incentive Plans
The allocation of share-based compensation expense in the unaudited condensed consolidated statements of operations was as follows:
 Three months ended
March 31,
(in thousands)20252024
Cost of goods sold$473 $429 
Selling, general and administrative6,070 6,563 
Research and development398 432 
Total compensation expense before income tax6,941 7,424 
Income tax benefit1,407 1,672 
Total compensation expense, net of income tax$5,534 $5,752 
v3.25.1
Accumulated Other Comprehensive Loss, Net of Tax (Tables)
 3 Months Ended
Mar. 31, 2025
Equity [Abstract]  
Schedule of Changes in Each Component of Accumulated Comprehensive Loss, Net of Tax Effects
The components of and adjustments to accumulated other comprehensive loss, net of tax, were as follows:
 ForeignInterestAccumulated
 ForeignExchangeRate SwapPension andOther
CurrencyDerivativeDerivativeOtherComprehensive
(in thousands)TranslationInstrumentsInstrumentsPostretirementLoss, Net of Tax
Balance as of December 31, 2024$(123,497)$4,772 $2 $(21,592)$(140,315)
Other comprehensive income (loss) before reclassifications8,798 (2,160)— (478)6,160 
Amounts reclassified from accumulated other comprehensive loss, net of tax— (411)(3)(149)(563)
Tax benefit — 738 1 127 866 
Balance as of March 31, 2025$(114,699)$2,939 $— $(22,092)$(133,852)
v3.25.1
Net Income per Common Share (Tables)
 3 Months Ended
Mar. 31, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Income Per Common Share
The following is a computation of basic and diluted net income per common share attributable to Acushnet Holdings Corp.:
 Three months ended
 March 31,
(in thousands, except share and per share amounts)20252024
Net income attributable to Acushnet Holdings Corp.$99,372 $87,762 
Weighted average number of common shares:
Basic61,325,623 64,621,122 
RSUs159,165 268,052 
Diluted61,484,788 64,889,174 
Net income per common share attributable to Acushnet Holdings Corp.:
Basic$1.62 $1.36 
Diluted$1.62 $1.35 
Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares
The following securities have been excluded from the calculation of diluted weighted-average common shares outstanding as their impact was determined to be anti-dilutive:
 Three months ended
 March 31,
 20252024
RSUs248,808 223,717 
v3.25.1
Segment Information (Tables)
 3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Information by Reportable Segment and a Reconciliation to Reported Amounts
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31, 2025
(in thousands)Titleist Golf EquipmentFootJoy Golf WearGolf GearTotal Reportable Segments
Other (1)
Total Consolidated
Net sales$421,092 $178,436 $70,963 $670,491 $32,881 $703,372 
Segment expenses:
Cost of goods sold206,524 104,232 40,824 351,580 
Advertising and promotion44,659 13,397 3,401 61,457 
Research and development16,344 1,310 675 18,329 
Selling, general and administrative75,269 34,927 11,649 121,845 
Other segment items (2)
2,448 55 648 3,151 
Other expenses— — — — 32,463 
Total operating income 75,848 24,515 13,766 114,129 418 114,547 
Reconciling items:
Interest expense, net(13,815)
Non-service cost component of net periodic benefit cost(869)
Other (3)
20,732 
Total income before income tax$120,595 
_________________________________
(1) Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.
(2) Other segment items primarily includes identifiable intangible asset amortization expense.
(3) Other includes a non-cash gain on deconsolidation of $20.9 million related to Lionscore (Note 1).
Information by reportable segment and a reconciliation to reported amounts are as follows:
Three months ended March 31, 2024
(in thousands)Titleist Golf EquipmentFootJoy Golf WearGolf GearTotal Reportable Segments
Other (1)
Total Consolidated
Net sales$411,873 $191,066 $69,513 $672,452 $35,102 $707,554 
Segment expenses:
Cost of goods sold192,132 112,940 43,956 349,028 
Advertising and promotion39,341 13,662 3,058 56,061 
Research and development14,382 1,035 595 16,012 
Selling, general and administrative71,804 36,448 11,629 119,881 
Other segment items (2)
2,451 55 649 3,155 
Restructuring costs (Note 16)
— — — — 6,967 
Other expenses— — — — 35,069 
Total operating income (loss)91,763 26,926 9,626 128,315 (6,934)121,381 
Reconciling items:
Interest expense, net(13,076)
Non-service cost component of net periodic benefit cost(776)
Other437 
Total income before income tax$107,966 
_________________________________
(1) Amounts represent operating segments that do not meet the quantitative thresholds to be a reportable segment, as well as unallocated corporate expenses. These non-reportable segments include two premium performance apparel businesses.
(2) Other segment items primarily includes identifiable intangible asset amortization expense.
Schedule of Net Sales By Geographical Area
Information as to the Company’s operations in different geographical areas is presented below. Net sales are categorized based on the location in which the sale originates.
Three months ended March 31,
(in thousands)20252024
United States$424,209 $418,243 
EMEA (1)
103,869 101,679 
Japan35,232 37,150 
Korea66,218 75,251 
Rest of World73,844 75,231 
Total net sales$703,372 $707,554 
_______________________________________________________________________________
(1) Europe, the Middle East and Africa ("EMEA")
v3.25.1
Restructuring Costs (Tables)
 3 Months Ended
Mar. 31, 2025
Restructuring and Related Activities [Abstract]  
Schedule of Company's Restructuring Programs
The activity related to these plans was as follows:
(in thousands)Three months ended March 31,
20252024
Balance at beginning of period$12,431 $— 
Provision— 6,967 
Payments(5,439)(4,720)
Deconsolidation of VIE (Note 1)
(6,992)— 
Balance at end of period$— $2,247 
v3.25.1
Summary of Significant Accounting Policies (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 30, 2025
Mar. 31, 2025
Mar. 31, 2024
Feb. 01, 2025
Dec. 31, 2024
Variable Interest Entity [Line Items]          
Deconsolidation of VIE (Note 1)   $ 20,887 $ 0    
Loss from equity method investment (Note 1)   223 0    
Accrued expenses and other liabilities   221,889     $ 180,430
Loan to minority shareholders included in temporary equity   4,400     4,400
Restricted cash   1,200     1,600
Selling, general and administrative          
Variable Interest Entity [Line Items]          
Transaction gain (loss) included in selling, general and administrative expense   1,400 $ (100)    
Equity Method Investee          
Variable Interest Entity [Line Items]          
Accrued expenses and other liabilities   7,200      
Lionscore          
Variable Interest Entity [Line Items]          
Investment at fair value   13,900   $ 14,100  
Loss from equity method investment (Note 1)   200      
VIE          
Variable Interest Entity [Line Items]          
Ownership percentage 40.00%        
Outstanding borrowings         0
Deconsolidation of VIE (Note 1)   20,900      
Accrued expenses and other liabilities   $ 0     $ 13,893
v3.25.1
Allowance for Credit Losses (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Accounts Receivable, Allowance for Credit Loss [Roll Forward]    
Balance at beginning of period $ 7,238 $ 8,840
(Decrease) increase in provision for expected credit losses (920) 312
Amount of receivables recovered (written off) 91 (196)
Foreign currency translation 124 (93)
Balance at end of period $ 6,533 $ 8,863
v3.25.1
Inventories (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Raw materials and supplies $ 131,842 $ 137,150
Work-in-process 29,978 33,549
Finished goods 376,321 405,265
Inventories $ 538,141 $ 575,964
v3.25.1
Product Warranty (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Activity for accrued warranty expense    
Balance at beginning of period $ 4,980 $ 4,997
Provision 1,441 1,537
Claims paid/costs incurred (1,266) (1,296)
Foreign currency translation 35 (56)
Balance at end of period $ 5,190 $ 5,182
Minimum    
Product Warranty Liability [Line Items]    
Product warranty period 1 year  
Maximum    
Product Warranty Liability [Line Items]    
Product warranty period 2 years  
v3.25.1
Debt and Financing Arrangements (Details) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
May 02, 2024
Unsecured Local Credit Facilities      
Line of Credit Facility [Line Items]      
Weighted average interest rate (as percent) 0.81% 0.61%  
Available borrowings $ 38,600,000    
Other short-term borrowings, outstanding borrowings $ 17,300,000 $ 10,200,000  
Senior Unsecured Notes due 2028 | Unsecured Local Credit Facilities      
Line of Credit Facility [Line Items]      
Debt instrument interest rate stated percentage 7.375% 7.375%  
Amount outstanding $ 350,000,000.0 $ 350,000,000.0  
Effective interest rate 7.813%    
Accrued interest $ 11,800,000 5,600,000  
Senior Unsecured Notes due 2028 | Unsecured Local Credit Facilities | Level 2      
Line of Credit Facility [Line Items]      
Fair value of notes 362,300,000 362,100,000  
Revolving Credit Facility      
Line of Credit Facility [Line Items]      
Maximum borrowing capacity     $ 950,000,000
Outstanding borrowings $ 577,600,000 $ 404,700,000  
Weighted average interest rate (as percent) 5.48% 5.51%  
Available borrowings $ 369,500,000    
Letters of credit outstanding 2,900,000    
Letters of Credit      
Line of Credit Facility [Line Items]      
Maximum borrowing capacity 58,800,000    
Outstanding borrowings 5,900,000 $ 5,700,000  
Line of credit secured $ 2,900,000 $ 2,900,000  
v3.25.1
Derivative Financial Instruments - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Foreign exchange forward    
Derivatives, Fair Value [Line Items]    
Expected reclassification of net gain (loss) recorded in accumulated other comprehensive gain (loss), net of tax into cost of goods sold during next twelve months $ 4.6  
Foreign exchange forward | Derivative Designated As Hedging    
Derivatives, Fair Value [Line Items]    
Notional amount 206.2 $ 192.2
Interest rate swap | Derivative Designated As Hedging    
Derivatives, Fair Value [Line Items]    
Notional amount $ 0.0 $ 100.0
Maximum | Foreign exchange forward    
Derivatives, Fair Value [Line Items]    
Term of derivative contract (in months) 24 months  
v3.25.1
Derivative Financial Instruments - Schedule of Fair Values of Hedge Instruments on the Unaudited Condensed Consolidated Balance Sheets (Details) - Derivative Designated As Hedging - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Foreign exchange forward | Prepaid and other assets    
Derivatives, Fair Value [Line Items]    
Asset derivatives $ 3,968 $ 8,135
Foreign exchange forward | Accrued expenses and other liabilities    
Derivatives, Fair Value [Line Items]    
Liability derivatives 1,704 251
Interest rate swap | Prepaid and other assets    
Derivatives, Fair Value [Line Items]    
Asset derivatives 0 4
Interest rate swap | Accrued expenses and other liabilities    
Derivatives, Fair Value [Line Items]    
Liability derivatives $ 0 $ 1
v3.25.1
Derivative Financial Instruments - Schedule of Effect of Hedge Instruments on Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Derivative Instruments, Gain (Loss) [Line Items]    
 Total $ (2,160) $ 3,921
Cash Flow Hedge | Derivative Designated As Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
 Total (2,160) 3,921
Foreign exchange forward | Cash Flow Hedge | Derivative Designated As Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
 Total (2,160) 3,342
Interest rate swap | Cash Flow Hedge | Derivative Designated As Hedging    
Derivative Instruments, Gain (Loss) [Line Items]    
 Total $ 0 $ 579
v3.25.1
Derivative Financial Instruments - Schedule of Effect of Hedge Instrument in the Unaudited Condensed Consolidated Statement of Operations (Details) - Derivative Designated As Hedging - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Foreign exchange forward    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized on unaudited condensed consolidated statements of operations $ (549) $ 3,461
Foreign exchange forward | Cost of goods sold    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized on unaudited condensed consolidated statements of operations $ 411 $ 2,738
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of goods sold Cost of goods sold
Foreign exchange forward | Selling, general and administrative    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized on unaudited condensed consolidated statements of operations $ (960) $ 723
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Selling, general and administrative Selling, general and administrative
Interest rate swap    
Derivative Instruments, Gain (Loss) [Line Items]    
Gain recognized on unaudited condensed consolidated statements of operations $ 3 $ 260
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Interest expense, net Interest expense, net
v3.25.1
Fair Value Measurements (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Level 1    
Assets    
Rabbi trust $ 2,520 $ 3,150
Deferred compensation program assets 600 633
Total assets 3,120 3,783
Liabilities    
Deferred compensation program liabilities 600 633
Total liabilities 600 633
Level 1 | Foreign exchange derivative instruments    
Assets    
Foreign exchange derivative instruments 0 0
Liabilities    
Derivative instruments, current 0 0
Level 1 | Interest rate derivative instruments    
Assets    
Interest rate derivative instruments   0
Liabilities    
Derivative instruments, current   0
Level 2    
Assets    
Rabbi trust 0 0
Deferred compensation program assets 0 0
Total assets 3,968 8,139
Liabilities    
Deferred compensation program liabilities 0 0
Total liabilities 1,704 252
Level 2 | Foreign exchange derivative instruments    
Assets    
Foreign exchange derivative instruments 3,968 8,135
Liabilities    
Derivative instruments, current 1,704 251
Level 2 | Interest rate derivative instruments    
Assets    
Interest rate derivative instruments   4
Liabilities    
Derivative instruments, current   1
Level 3    
Assets    
Rabbi trust 0 0
Deferred compensation program assets 0 0
Total assets 0 0
Liabilities    
Deferred compensation program liabilities 0 0
Total liabilities 0 0
Level 3 | Foreign exchange derivative instruments    
Assets    
Foreign exchange derivative instruments 0 0
Liabilities    
Derivative instruments, current $ 0 0
Level 3 | Interest rate derivative instruments    
Assets    
Interest rate derivative instruments   0
Liabilities    
Derivative instruments, current   $ 0
v3.25.1
Pension and Other Postretirement Benefits (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Pension Benefits    
Components of net periodic benefit cost (credit)    
Service cost $ 1,279 $ 1,325
Interest cost 2,892 2,703
Expected return on plan assets (2,017) (1,838)
Amortization of net loss (gain) 67 58
Amortization of prior service cost (credit) 22 23
Net periodic benefit cost (credit) 2,243 2,271
Postretirement Benefits    
Components of net periodic benefit cost (credit)    
Service cost 90 91
Interest cost 143 133
Expected return on plan assets 0 0
Amortization of net loss (gain) (237) (269)
Amortization of prior service cost (credit) (1) (34)
Net periodic benefit cost (credit) $ (5) $ (79)
v3.25.1
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Tax Disclosure [Abstract]    
Decrease in income tax expense $ 1,800  
Income tax expense $ 21,570 $ 23,407
Effective tax rate (as percent) 17.90% 21.70%
v3.25.1
Common Stock - Schedule of Declared Dividends Per Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2024
Equity [Abstract]            
Dividends per Common Share (in dollars per share) $ 0.235 $ 0.215 $ 0.215 $ 0.215 $ 0.215 $ 0.860
Amount $ 14,576 $ 13,476 $ 13,787 $ 13,873 $ 14,155 $ 55,291
v3.25.1
Common Stock - Narrative (Details) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Jul. 10, 2024
May 07, 2025
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2024
Apr. 10, 2025
Dec. 17, 2024
Dividends Payable [Line Items]                    
Dividends per Common Share (in dollars per share)     $ 0.235 $ 0.215 $ 0.215 $ 0.215 $ 0.215 $ 0.860    
Issued and outstanding common stock authorized to repurchase     $ 1,250,000,000              
Aggregate value     $ 36,637,000       $ 35,302,000      
Accrued share repurchase (in shares)     1,476,851 935,907       935,907    
Share repurchase liability     $ 99,100,000              
Satisfaction of obligation under agreement     415,500,000              
Excise tax accrued     200,000              
Treasury Stock                    
Dividends Payable [Line Items]                    
Aggregate value     $ 36,600,000              
Treasury share retirement (in shares)     540,944              
Magnus                    
Dividends Payable [Line Items]                    
Aggregate value $ 37,500,000                  
Stock repurchase program, authorized amount                   $ 62,500,000
Accrued share repurchase (in shares) 587,520   935,907 935,907       935,907   540,944
Share repurchase liability     $ 62,500,000 $ 62,500,000       $ 62,500,000   $ 36,600,000
Subsequent Event                    
Dividends Payable [Line Items]                    
Dividends per Common Share (in dollars per share)   $ 0.235                
Subsequent Event | Magnus                    
Dividends Payable [Line Items]                    
Stock repurchase program, authorized amount                 $ 62,500,000  
Accrued share repurchase (in shares)                 935,907  
v3.25.1
Common Stock - Schedule of Share Repurchase Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dividends Payable [Line Items]    
Shares repurchased (in shares) 540,944 547,233
Average price (in dollars per share) $ 67.73 $ 64.51
Aggregate value $ 36,637 $ 35,302
Open Market    
Dividends Payable [Line Items]    
Shares repurchased (in shares) 540,944 547,233
Average price (in dollars per share) $ 67.73 $ 64.51
Aggregate value $ 36,637 $ 35,302
Treasury stock, value repurchased not settled $ 1,000 $ 2,000
v3.25.1
Equity Incentive Plans - Narrative (Details)
$ in Millions
 3 Months Ended
Mar. 31, 2025
USD ($)
RSUs | 2015 Omnibus Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation expense $ 37.3
Weighted average period (in years) 1 year 7 months 6 days
RSUs | Company Officers  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting period (in years) 3 years
Vesting percentage 33.33%
RSUs | Officers, Employees, Consultants and Advisors  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting period (in years) 3 years
Vesting percentage 33.33%
PSUs  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Performance period (in years) 3 years
PSUs | 2015 Omnibus Incentive Plan  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized compensation expense $ 20.6
Weighted average period (in years) 2 years 2 months 12 days
PSUs | Officers, Employees, Consultants and Advisors | Minimum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting percentage 0.00%
PSUs | Officers, Employees, Consultants and Advisors | Maximum  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Vesting percentage 200.00%
v3.25.1
Equity Incentive Plans - Schedule of Restricted and Performance Stock Units (Details) - 2015 Omnibus Incentive Plan
 3 Months Ended
Mar. 31, 2025
$ / shares
shares
RSUs  
Number of Units  
Outstanding at beginning of the period (in shares) 668,030
Granted (in shares) 309,497
Vested (in shares) (310,309)
Forfeited (in shares) (1,583)
Outstanding at end of the period (in shares) 665,635
Weighted - Average Fair Value  
Outstanding at beginning of the period (in dollars per share) | $ / shares $ 56.40
Granted (in dollars per share) | $ / shares 68.21
Vested (in dollars per share) | $ / shares 52.77
Forfeited (in dollars per share) | $ / shares 59.94
Outstanding at end of the period (in dollars per share) | $ / shares $ 63.58
Undelivered (in shares) 36,934
Vested (in shares) 310,309
PSUs  
Number of Units  
Outstanding at beginning of the period (in shares) 500,967
Granted (in shares) 165,248
Vested (in shares) (151,848)
Forfeited (in shares) (528)
Outstanding at end of the period (in shares) 513,839
Weighted - Average Fair Value  
Outstanding at beginning of the period (in dollars per share) | $ / shares $ 52.66
Granted (in dollars per share) | $ / shares 68.21
Vested (in dollars per share) | $ / shares 43.96
Forfeited (in dollars per share) | $ / shares 59.95
Outstanding at end of the period (in dollars per share) | $ / shares $ 60.23
Vested (in shares) 151,848
Achieved target level of performance (in percent) 100.00%
PSUs | Common Stock  
Number of Units  
Vested (in shares) (75,693)
Weighted - Average Fair Value  
Undelivered (in shares) 196,795
Vested (in shares) 75,693
v3.25.1
Equity Incentive Plans - Schedule of Compensation Expense Recorded in the Consolidated Statement of Operations (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense $ 6,941 $ 7,424
RSUs | 2015 Omnibus Incentive Plan    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense 5,032 4,496
PSUs | 2015 Omnibus Incentive Plan    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Compensation expense $ 1,909 $ 2,764
v3.25.1
Equity Incentive Plans - Schedule of Shares of Common Stock Issued (Details) - 2015 Omnibus Incentive Plan - shares
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
RSUs    
Class of Stock [Line Items]    
Cumulative undelivered shares of common stock (in shares) 36,934  
Common Stock | RSUs    
Class of Stock [Line Items]    
Shares of common stock issued (in shares) 273,390 418,829
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares) (93,949) (137,107)
Net shares of common stock issued (in shares) 179,441 281,722
Cumulative undelivered shares of common stock (in shares) 517,542 485,027
Common Stock | PSUs    
Class of Stock [Line Items]    
Shares of common stock issued (in shares) 121,102 219,831
Shares of common stock withheld by the Company as payment by employees in lieu of cash to satisfy tax withholding obligations (in shares) (53,209) (95,814)
Net shares of common stock issued (in shares) 67,893 124,017
Cumulative undelivered shares of common stock (in shares) 546,789 471,078
v3.25.1
Equity Incentive Plans - Schedule of Compensation Expense Related to Equity Incentive Plans (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax $ 6,941 $ 7,424
Income tax benefit 1,407 1,672
Total compensation expense, net of income tax 5,534 5,752
Cost of goods sold    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax 473 429
Selling, general and administrative    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax 6,070 6,563
Research and development    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Total compensation expense before income tax $ 398 $ 432
v3.25.1
Accumulated Other Comprehensive Loss, Net of Tax (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance $ 793,136
Other comprehensive income (loss) before reclassifications 6,160
Amounts reclassified from accumulated other comprehensive loss, net of tax (563)
Tax benefit 866
Ending balance 780,284
Foreign Currency Translation  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance (123,497)
Other comprehensive income (loss) before reclassifications 8,798
Amounts reclassified from accumulated other comprehensive loss, net of tax 0
Tax benefit 0
Ending balance (114,699)
Gains (Losses) on Derivative Instruments | Foreign Exchange Derivative Instruments  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance 4,772
Other comprehensive income (loss) before reclassifications (2,160)
Amounts reclassified from accumulated other comprehensive loss, net of tax (411)
Tax benefit 738
Ending balance 2,939
Gains (Losses) on Derivative Instruments | Interest rate swap  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance 2
Other comprehensive income (loss) before reclassifications 0
Amounts reclassified from accumulated other comprehensive loss, net of tax (3)
Tax benefit 1
Ending balance 0
Pension and Other Postretirement  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance (21,592)
Other comprehensive income (loss) before reclassifications (478)
Amounts reclassified from accumulated other comprehensive loss, net of tax (149)
Tax benefit 127
Ending balance (22,092)
Accumulated Other Comprehensive Loss, Net of Tax  
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]  
Beginning balance (140,315)
Ending balance $ (133,852)
v3.25.1
Net Income per Common Share - Schedule of Computation of Basic and Diluted Net Income Per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Net income attributable to Acushnet Holdings Corp. $ 99,372 $ 87,762
Weighted average number of common shares:    
Basic (in shares) 61,325,623 64,621,122
Diluted (in shares) 61,484,788 64,889,174
Net income per common share attributable to Acushnet Holdings Corp.:    
Basic (in dollars per share) $ 1.62 $ 1.36
Diluted (in dollars per share) $ 1.62 $ 1.35
RSUs    
Weighted average number of common shares:    
Basic (in shares) 159,165 268,052
v3.25.1
Net Income per Common Share - Schedule of Securities Excluded From the Calculation of Diluted Weighted Average Common Shares (Details) - shares
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
RSUs    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Anti-dilutive securities excluded from computation of earnings per share (in shares) 248,808 223,717
v3.25.1
Segment Information - Reconciliation (Details)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 3  
Segment Reporting Information [Line Items]    
Net sales $ 703,372 $ 707,554
Segment expenses:    
Cost of goods sold 366,210 365,202
Research and development 18,859 16,453
Selling, general and administrative 200,261 201,005
Income from operations 114,547 121,381
Reconciling items:    
Interest expense, net (13,815) (13,076)
Income before income taxes $ 120,595 107,966
Number of non-reportable segments | segment 2  
Gain on deconsolidation of VIE (Note 1) $ (20,887) 0
VIE    
Reconciling items:    
Gain on deconsolidation of VIE (Note 1) (20,900)  
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 670,491 672,452
Segment expenses:    
Cost of goods sold 351,580 349,028
Advertising and promotion 61,457 56,061
Research and development 18,329 16,012
Selling, general and administrative 121,845 119,881
Other segment items 3,151 3,155
Restructuring costs (Note 16)   0
Other expenses 0 0
Income from operations 114,129 128,315
Other    
Segment Reporting Information [Line Items]    
Net sales 32,881 35,102
Segment expenses:    
Restructuring costs (Note 16)   6,967
Other expenses 32,463 35,069
Income from operations 418 (6,934)
Reconciling Items    
Reconciling items:    
Interest expense, net (13,815) (13,076)
Non-service cost component of net periodic benefit cost (869) (776)
Other 20,732 437
Titleist Golf Equipment | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 421,092 411,873
Segment expenses:    
Cost of goods sold 206,524 192,132
Advertising and promotion 44,659 39,341
Research and development 16,344 14,382
Selling, general and administrative 75,269 71,804
Other segment items 2,448 2,451
Restructuring costs (Note 16)   0
Other expenses 0 0
Income from operations 75,848 91,763
FootJoy Golf Wear | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 178,436 191,066
Segment expenses:    
Cost of goods sold 104,232 112,940
Advertising and promotion 13,397 13,662
Research and development 1,310 1,035
Selling, general and administrative 34,927 36,448
Other segment items 55 55
Restructuring costs (Note 16)   0
Other expenses 0 0
Income from operations 24,515 26,926
Golf Gear | Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 70,963 69,513
Segment expenses:    
Cost of goods sold 40,824 43,956
Advertising and promotion 3,401 3,058
Research and development 675 595
Selling, general and administrative 11,649 11,629
Other segment items 648 649
Restructuring costs (Note 16)   0
Other expenses 0 0
Income from operations $ 13,766 $ 9,626
v3.25.1
Segment Information - Schedule of Net Sales By Geographical Area (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales $ 703,372 $ 707,554
United States    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 424,209 418,243
EMEA    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 103,869 101,679
Japan    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 35,232 37,150
Korea    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales 66,218 75,251
Rest of World    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Total net sales $ 73,844 $ 75,231
v3.25.1
Restructuring Costs - Schedule of Company's Restructuring Program Rollforward (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Restructuring Reserve [Roll Forward]    
Deconsolidation of VIE (Note 1) $ 20,887 $ 0
Facility Closing | Initial Plan    
Restructuring Reserve [Roll Forward]    
Balance at beginning of period 12,431 0
Provision 0 6,967
Payments (5,439) (4,720)
Deconsolidation of VIE (Note 1) (6,992) 0
Balance at end of period $ 0 $ 2,247
v3.25.1
Restructuring Costs - Additional Information (Details)
Mar. 31, 2025
USD ($)
Facility Closing | Initial Plan  
Restructuring Cost and Reserve [Line Items]  
Expected remaining cost $ 0